Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08FBB
|
|||
Former ID |
DNC012373
|
|||
Drug Name |
8-Ethyl-3-hydroxy-1H-benzo[b]azepine-2,5-dione
|
|||
Synonyms |
1H-1-Benzazepine-2,5-dione, 8-ethyl-3-hydroxy-; SCHEMBL9389409; CHEMBL143292; 183663-81-2
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H11NO3
|
|||
Canonical SMILES |
CCC1=CC2=C(C=C1)C(=CC(=O)C(=O)N2)O
|
|||
InChI |
1S/C12H11NO3/c1-2-7-3-4-8-9(5-7)13-12(16)11(15)6-10(8)14/h3-6,14H,2H2,1H3,(H,13,15,16)
|
|||
InChIKey |
FPLGJFSMGRDPES-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites. J Med Chem. 1996 Nov 8;39(23):4643-53. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.